You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 7, July 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Neutron Radiotherapy for Adenoid Cystic Carcinoma of the Head and Neck

Thomas A. Buchholz, MD; Steven G. Shimotakahara, MD; Ernest A. Weymuller, Jr, MD; George E. Laramore, PhD, MD; Thomas W. Griffin, MD

Arch Otolaryngol Head Neck Surg. 1993;119(7):747-752.


Abstract

• Achieving local control in patients with advanced adenoid cystic carcinoma continues to be a therapeutic challenge. From 1984 to 1990, we treated 34 patients with advanced adenoid cystic carcinoma of the head and neck with fast neutron radiation. Patients treated for minimal microscopic disease following surgery were not included in this study. Neutron radiotherapy achieved 5-year actuarial local control and locoregional control rates of 76% and 63%, respectively. Five-year actuarial overall survival and disease-specific survival rates were 65% and 93%, respectively. Eighty-one percent (17/21) of patients treated with neutron therapy alone and 100% (13/13) of the patients treated with neutron therapy and surgery achieved local control. All seven patients with paranasal sinus malignant neoplasms achieved local control. The success achieved in this prognostically unfavorable population affirms the important role of neutron radiotherapy in the treatment of adenoid cystic carcinoma.

(Arch Otolaryngol Head Neck Surg. 1993;119:747-752)



Author Affiliations

From the Departments of Radiation Oncology (Drs Buchholz, Laramore, and Griffin) and Head and Neck Surgery (Drs Shimotakahara and Weymuller), University of Washington Medical Center, Seattle.


Footnotes

Accepted for publication December 30, 1992.

Presented at the Third International Conference on Head and Neck Cancer, San Francisco, Calif, July 26, 1992.

Reprint requests to Department of Radiation Oncology, RC-08, University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195 (Dr Buchholz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

RESIDENTS PAGE: PATHOLOGY
ASKIN and WESTRA
Arch Otolaryngol Head Neck Surg 1995;121:1320-1323.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.